Javed, A.; Malagraba, G.; Yarmohammadi, M.; Perelló-Reus, C.M.; Barceló, C.; Rubio-Tomás, T.
Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System. Future Pharmacol. 2022, 2, 214-237.
https://doi.org/10.3390/futurepharmacol2030015
AMA Style
Javed A, Malagraba G, Yarmohammadi M, Perelló-Reus CM, Barceló C, Rubio-Tomás T.
Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System. Future Pharmacology. 2022; 2(3):214-237.
https://doi.org/10.3390/futurepharmacol2030015
Chicago/Turabian Style
Javed, Aadil, Gianluca Malagraba, Mahdieh Yarmohammadi, Catalina M. Perelló-Reus, Carles Barceló, and Teresa Rubio-Tomás.
2022. "Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System" Future Pharmacology 2, no. 3: 214-237.
https://doi.org/10.3390/futurepharmacol2030015
APA Style
Javed, A., Malagraba, G., Yarmohammadi, M., Perelló-Reus, C. M., Barceló, C., & Rubio-Tomás, T.
(2022). Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System. Future Pharmacology, 2(3), 214-237.
https://doi.org/10.3390/futurepharmacol2030015